Rapid Resolution of Liver Metastasis from Cholangiocarcinoma after Bevacizumab with Cisplatin and High-Dose Fluorouracil plus Leucovorin

Publisher： Karger

E-ISSN： 2296-5262|29|4|179-180

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.4, 2006-03, pp. : 179-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 104-113

Karger

Access to resources Recommend Favorite

A Phase I Study of Weekly Docetaxel, 24-Hour Infusion of High-Dose Fluorouracil/Leucovorin and Cisplatin in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

Bevacizumab plus Irinotecan-, Fluorouracil-, and Leucovorin-Based Chemotherapy with Concomitant HAART in an HIV-Positive Patient with Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 7, 2008-06 ,pp. : 394-397

Karger

Access to resources Recommend Favorite

5-Fluorouracil, Leucovorin and Oxaliplatin plus Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer: A Single-Institute Study

By  

Oncology, Vol. 72, Iss. 1-2, 2007-10 ,pp. : 4-9

Karger

Access to resources Recommend Favorite

A Phase II Study of Irinotecan Alternated with a Weekly Schedule of Oxaliplatin, High-Dose Leucovorin and 48-Hour Infusion 5-Fluorouracil in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 371-378

Karger

Access to resources Recommend Favorite